Skip to content
thispeptide

Rila

Rila offers clinician-reviewed compounded semaglutide and tirzepatide as injections or dissolving tablets. It names its clinical partner and several possible pharmacies, while the actual assignment still needs confirmation.

Review by Molly Ward, goal-guide writer · Updated October 2026

The short version

The disclosed network helps identify the service behind the storefront. Ask who treats you, which pharmacy fills the prescription and what follow-up applies to the selected formulation.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

BJE Equity LLC operates Rila as a platform connecting patients with independent professionals. Its weight-management menu describes semaglutide and tirzepatide in two forms, once-weekly injections and dissolving tablets. The site says compounded products are not FDA-approved. Choosing between routes should involve a clinical discussion rather than an assumption that the same ingredient produces equivalent absorption or outcomes.

What Rila prescribes, by goal

Weight

  • SemaglutideFDA-approved
    • Injection (compounded)Price not published
    • Oral (compounded)Price not published
  • TirzepatideFDA-approved
    • Injection (compounded)Price not published
    • Oral (compounded)Price not published

The injection and dissolving-tablet options are different preparations. Research on an approved injectable product does not establish the same benefit or safety for a compounded tablet. Ask what evidence supports the proposed formulation and how side effects affect dose changes.

Who prescribes

A licensed clinician

The named clinical network is DrTelx. Pharmacy partners listed include EPIQ Scripts, Foothills Professional Pharmacy and Emerald Pharmacy. The assigned prescriber and dispensing address are not specified for every patient. Ask which professional reviews your history and whether that person handles later refills. The pharmacy list identifies possible partners, not proof of your particular prescription’s source.

An online questionnaire precedes provider review. Rila describes asynchronous care where permitted and live consultations in specified jurisdictions. Its care journey includes progress check-ins during the first month and messaging between refills. Ask whether those check-ins involve the prescriber and what prompts another appointment. The platform’s own assessment does not itself establish a physician-patient relationship or guarantee a prescription.

Are labs required?

Not mentioned

The public program does not establish one included testing panel or repeat schedule. Telehealth consent permits exchanging laboratory information, which is different from including new tests. Ask whether the clinician needs baseline results, who interprets them and whether testing adds to the bill.

Ready to start with Rila?

Prices and plans are set on the seller's own site.

What it claims, and what it cites

Rila states that some reported outcomes come from self-reported weights and acknowledges illustrative images. Neither establishes a typical individual result. Its named pharmacy history also needs context: FDA issued Foothills a 2020 warning, while the agency’s index records a March 2022 closeout. That historical record does not establish a current problem with an individual Rila prescription or global pharmacy clearance.

Other products and treatment claims

Optional anti-nausea support
A separate supportive prescription is not an additional peptide program or guaranteed inclusion for every patient.

How it bills

The lowest injection and tablet figures require a six-month commitment. The refund policy separately describes monthly automatic renewal, so obtain the selected plan’s actual obligation. An initial clinical decline is refunded in full, while ordinary cancellation does not refund a billed cycle. Medical discontinuation has a narrower unused-services rule. The difference matters if treatment changes before a longer commitment ends.

For and against

  • For: Clinical partner network named publicly
  • For: Several possible pharmacies identified
  • For: Route and approval limitations disclosed
  • For: First-month check-ins and messaging described
  • Against: Assigned clinician still needs confirmation
  • Against: Actual dispensing location varies by order
  • Against: Tablet evidence cannot inherit injection results
  • Against: Testing and commitment terms need clarification

The evidence behind what it sells

Right for

Someone comparing clinical access and pharmacy assignment before choosing a compounded preparation.

Look elsewhere if

Someone assuming the same ingredient guarantees equivalent outcomes across injection and dissolving-tablet routes.

Other sellers for weight

Rila

Frequently asked questions

Does the pharmacy list guarantee which one fills my prescription?
No. Confirm the actual dispensing business and address before treatment.
Are the tablets FDA-approved oral GLP-1 products?
The site describes compounded tablets and states its compounded preparations are not FDA-approved.
Does the historical Foothills letter prove a Rila order was affected?
No. The record concerns a named facility and period, and FDA’s index also records a later closeout.

Sources

See what Rila prescribes today

Rila sets its own prices, plans and the states it serves. Check them before you start.

Written by Molly Ward from Rila’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.